Time course of clinical and neuroradiological effects of delayed-release dimethyl fumarate in multiple sclerosis
about
Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapyMRI utility in the detection of disease activity in clinically stable patients with multiple sclerosis: a retrospective analysis of a community based cohort.Onset of clinical and MRI efficacy occurs early after fingolimod treatment initiation in relapsing multiple sclerosis.Safety and Tolerability of Delayed-Release Dimethyl Fumarate Administered with Interferon Beta or Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis.Fumarate modulates the immune/inflammatory response and rescues nerve cells and neurological function after stroke in rats.Dimethyl Fumarate and Monomethyl Fumarate Promote Post-Ischemic Recovery in Mice.Efficacy and Tolerability of Delayed-release Dimethyl Fumarate in Black, Hispanic, and Asian Patients with Relapsing-Remitting Multiple Sclerosis: Post Hoc Integrated Analysis of DEFINE and CONFIRM.Dimethyl Fumarate: A Review in Relapsing-Remitting MS.Relapse frequency in transitioning from natalizumab to dimethyl fumarate: assessment of risk factors.Multiple Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways Explain the Frequent Presence of Depression in Multiple Sclerosis.Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS.
P2860
Q26738969-BA5DB65B-217A-48C9-A7E8-92A109C32BE5Q36141526-3BB653FC-59D9-4D77-B9D8-8202352A28A7Q36573403-F42D2914-8D57-4F1B-B541-A6F111F0328FQ36951371-FAC022EF-10E4-4F0E-8C72-830EA6F1824AQ37336648-568D737A-33D9-4244-855C-9424BDB4B2D1Q37341841-FD0C2033-BFE9-4C5B-BE6F-1501CD9B5C4FQ38372793-A818E989-5885-415B-8DA8-DF01D0555907Q38675014-F30EFF54-01AB-474D-A9A9-A2CBD43A5165Q40747927-0B5F1008-2DE0-4764-B65F-0FEB101DA6A0Q47559443-835BC02E-8CCC-42E6-A0A1-231DBE678574Q53338098-02981CB7-75EC-40EE-B12C-CC1A945A7DDD
P2860
Time course of clinical and neuroradiological effects of delayed-release dimethyl fumarate in multiple sclerosis
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Time course of clinical and ne ...... fumarate in multiple sclerosis
@ast
Time course of clinical and ne ...... fumarate in multiple sclerosis
@en
type
label
Time course of clinical and ne ...... fumarate in multiple sclerosis
@ast
Time course of clinical and ne ...... fumarate in multiple sclerosis
@en
prefLabel
Time course of clinical and ne ...... fumarate in multiple sclerosis
@ast
Time course of clinical and ne ...... fumarate in multiple sclerosis
@en
P2093
P2860
P356
P1476
Time course of clinical and ne ...... fumarate in multiple sclerosis
@en
P2093
C Hotermans
D L Arnold
DEFINE and CONFIRM study investigators
J T Phillips
V Viglietta
P2860
P304
P356
10.1111/ENE.12624
P577
2015-01-02T00:00:00Z